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Mycobacterial infections are major causes of morbidity and mortality in cattle and are also
potential zoonotic agents with implications for human health. Despite the implementa-
tion of comprehensive animal surveillance programs, many mycobacterial diseases have
remained recalcitrant to eradication in several industrialized countries.Two major mycobac-
terial pathogens of cattle are Mycobacterium bovis and Mycobacterium avium subspecies
paratuberculosis (MAP), the causative agents of bovine tuberculosis (BTB) and Johne’s
disease (JD), respectively. BTB is a chronic, granulomatous disease of the respiratory tract
that is spread via aerosol transmission, while JD is a chronic granulomatous disease of
the intestines that is transmitted via the fecal-oral route. Although these diseases exhibit
differential tissue tropism and distinct complex etiologies, both M. bovis and MAP infect,
reside, and replicate in host macrophages – the key host innate immune cell that encoun-
ters mycobacterial pathogens after initial exposure and mediates the subsequent immune
response.The persistence of M. bovis and MAP in macrophages relies on a diverse series
of immunomodulatory mechanisms, including the inhibition of phagosome maturation and
apoptosis, generation of cytokine-induced necrosis enabling dissemination of infection
through the host, local pathology, and ultimately shedding of the pathogen. Here, we
review the bovine macrophage response to infection with M. bovis and MAP. In particu-
lar, we describe how recent advances in functional genomics are shedding light on the
host macrophage–pathogen interactions that underlie different mycobacterial diseases.
To illustrate this, we present new analyses of previously published bovine macrophage
transcriptomics data following in vitro infection with virulent M. bovis, the attenuated vac-
cine strain M. bovis BCG, and MAP, and discuss our findings with respect to the differing
etiologies of BTB and JD.
Keywords: cattle, BCG, gene expression, Johne’s disease, macrophage,Mycobacterium avium subspecies paratu-
berculosis,Mycobacterium bovis, tuberculosis
INTRODUCTION
Mycobacterium is a Gram-positive genus of Actinobacteria that
includes more than 120 species (1, 2). Although the majority of
species in this genus are non-pathogenic environmental bacteria, a
few species are highly successful intracellular pathogens of human
beings and other mammals including Mycobacterium tuberculosis
and Mycobacterium bovis – the causative agents of human being
and bovine tuberculosis (BTB), respectively – and Mycobacterium
avium subspecies paratuberculosis (MAP), the causative agent of
Johne’s disease (JD) in cattle (3, 4). The success of these patho-
genic mycobacteria is partly due to their ability to infect, reside,
and proliferate inside host macrophages, despite the antimicrobial
properties of these cells. Macrophages serve as key effector innate
immune cells that mediate the initial host response to infection
via the activity of inflammatory cytokines and chemokines; this
initial interaction leads to either the eradication of intracellular
bacilli or the formation of organized collections of immune cells,
termed granulomas, which contain infection (5).
Infections with pathogenic mycobacteria can manifest as acute
or chronic disease or involve lengthy subclinical phases of infection
with the potential to reactivate later. It is also understood that the
establishment of successful infection is underpinned by subver-
sion and modulation of host macrophage antimicrobial mech-
anisms, including the prevention of macrophage phagosome–
lysosome fusion, inhibition of macrophage apoptosis, and sup-
pression of antigen presentation and signaling mechanisms within
the macrophage (6–8). Furthermore, it has been proposed that
virulent mycobacteria exploit host defense mechanisms, such
as the induction of cytokine-induced necrosis, which results in
immunopathology, the dissemination of infection through the
host and ultimately pathology that leads to shedding of the
pathogen from the host, thereby maintaining the cycle of infection
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(9). Consequently, investigating the complex interplay between
mycobacterial pathogens and the host macrophage is critical to
our understanding of the immuno-pathogenesis of mycobacterial
diseases.
THEMycobacterium tuberculosis COMPLEX
The genus Mycobacterium contains the Mycobacterium tuberculo-
sis complex (MTBC) that includes seven major pathogenic species
and subspecies that cause tuberculosis in a range of mammalian
hosts, the most well-studied member of which is M. tuberculo-
sis – the causative agent of human tuberculosis. Typically, the
members of the MTBC display greater than 99.95% nucleotide
sequence identity at the genome level, with little or no evidence
for the exchange of genetic material between species and strains
(10). Despite this high level of genome similarity, the members
of the MTBC differ with respect to host range and pathogenicity:
M. tuberculosis and Mycobacterium africanum are almost exclu-
sively human pathogens; Mycobacterium microti causes disease in
rodents including voles; Mycobacterium pinnipedii causes tuber-
culosis in marine mammals including seals and sea lions; and
Mycobacterium caprae is very closely related to M. bovis and infects
both goats and deer. The species with the largest host range is
M. bovis, which is mainly isolated from cattle, but can also be
responsible for outbreaks in wild animals. Furthermore, M. bovis
can cause disease in human beings yet rarely transmits between
immunocompetent hosts. A closely related mycobacterial species,
Mycobacterium canettii, causes pathology in human beings, but
differs from the other members of the MTBC in that it displays
smooth colony morphology rather than the characteristic rough
morphology of the other MTBC members (11, 12).
Phylogenetic analyses using insertion/deletion DNA sequence
polymorphisms (indels), such as the variable regions of difference
(RD – see below) and whole gene and genome sequences have
revealed that the evolutionary history of the MTBC represents
a pattern of genome downsizing characterized by chromosomal
DNA sequence deletions and the inability of these species to repair
deletions through recombinogenic processes (10, 13). These stud-
ies support a distinct phylogenetic position of M. canettii from
all other MTBC members: M. canettii strains possess intact RD
sequences that are absent from the other MTBC species together
with one species-specific deletion (RDcan). M. canettii strains
also have 26 additional spacer sequences that are not found in
other MTBC species [Figure 1] (10). Indeed, it has been recently
proposed that M. canettii and other smooth tubercle bacilli (STB)
lineages diverged from the common ancestor of all tubercle bacilli
prior to the clonal radiation of non-smooth MTBC lineages
FIGURE 1 | Neighbor-joining phylogeny of selected mycobacteria
species and strains based on partial 16S rRNA sequences.
Bootstrap supports are based on 1,000 pseudoreplicates. Species and
strains belonging to the Mycobacterium tuberculosis complex are
shaded in red; members of the Mycobacterium avium complex are
shaded in green.
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and that non-smooth MTBC lineages evolved from an STB-like
mycobacterial ancestor, sometimes referred to as Mycobacterium
prototuberculosis (14).
Genomic comparisons across the MTBC revealed a number of
“regions of difference” (RD loci), with the presence or absence
of these loci capable of differentiating the constituent strains of
the MTBC. Notably, deletion of chromosomal region RD9 dis-
tinguishes M. tuberculosis strains from animal-adapted lineages,
including M. bovis, while RD1 [which encodes, among other genes,
the ESX-1 secretion system plus key secreted effectors including
early secretory antigen target 6 (ESAT-6) and culture filtrate pro-
tein 10 (CFP-10)] is deleted in M. bovis Bacille Calmette–Guérin
(M. bovis BCG) vaccine strains. The use of deletions to differen-
tiate mycobacterial strains led to the proposal of an evolutionary
scenario positing M. tuberculosis as being closer to the common
ancestor of the MTBC and rejection of the hypothesis that M.
tuberculosis infection in human populations arose from an animal
pathogen such as M. bovis in parallel with cattle domestication
and husbandry (15, 16).
THEMycobacterium avium COMPLEX
A second major evolutionarily distinct cluster of mycobacte-
rial species is represented by the Mycobacterium avium com-
plex [MAC] (Figure 1). This complex shares an estimated 40%
nucleotide sequence similarity with members of the MTBC based
on proteome-derived DNA sequences (17). The MAC com-
prises several closely related, slow-growing, pathogenic, and non-
pathogenic species. Among the pathogenic species within the MAC
are M. avium and its subspecies (MAP; M. avium subsp. avium;
M. avium subsp. silvaticum; and M. avium subsp. hominissuis) and
Mycobacterium intracellulare. Phylogenetic analyses based on par-
tial gene, whole gene, and complete genome DNA sequences have
revealed that subspecies of M. avium typically share over ≥95%
nucleotide sequence identity, while nucleotide identity between
M. avium subspecies and M. intracellulare was estimated between
80 and 94% (18–21).
Despite their genetic similarity, members of the MAC show dif-
ferential host and tissue tropisms. For example, M. avium subsp.
avium is the classical causative agent of tuberculosis in birds, while
M. avium subsp. silvaticum has been shown to cause tubercu-
lous lesions in wood pigeons. In this regard, M. avium subsp.
avium and M. avium subsp. silvaticum together represent a dis-
tinct lineage of avian pathogens. M. avium subsp. hominissuis and
M. intracellulare are opportunistic pathogens widely distributed
in the environment and can cause disseminated tuberculosis and
pulmonary disease in a range of mammalian hosts, including pigs,
cattle, and human beings (22). From a human perspective, M.
avium subsp. hominissuis is considered to be most clinically rele-
vant member of the MAC member, where it has been previously
shown to have caused disseminated infections among immuno-
compromised patients (23). MAP, in contrast, is an obligate intra-
cellular pathogen of ruminants that causes JD characterized by
chronic enteritis, with severe economic losses for the dairy indus-
try in many countries (3). MAP can be differentiated from the
other subspecies of M. avium by its very slow growth rate in vitro
(between 8 and 24 weeks growth is required for visible colony
formation). In addition, MAP is dependent on the siderophore
mycobactin J, an iron-chelating cell wall component, for growth
in primary cultures (24).
Mycobacterium bovis INFECTION AND BOVINE
TUBERCULOSIS
Bovine tuberculosis is caused by infection with M. bovis, which
continues to pose a threat to livestock worldwide. Furthermore,
as a zoonotic pathogen, M. bovis also has serious implications
for human health (25). It has been estimated that BTB con-
tributes losses of $3 billion to global agriculture annually (26, 27),
while comprehensive econometric analyses place BTB as the fourth
most important livestock disease worldwide (28). The impacts of
BTB infection are manifold, including significant economic and
social effects due to the slaughter of infected animals, compen-
satory payments to producers, continual surveillance programs,
and disruption to agricultural trade and productivity (29).
Bovine tuberculosis is predominantly a pulmonary disease,
characterized largely by the formation of tuberculous lesions in
the upper respiratory lymph nodes of the lung and thorax. In
some cases, tuberculous lesions have also been detected in the cra-
nial lymph nodes (30). The etiology and host immune response to
M. bovis is similar to M. tuberculosis infections in human beings
(31). Infection is normally caused by the inhalation of aerosolized
respiratory secretions containing infectious bacilli, with the nat-
ural site of infection being the respiratory tract, presumably on
the alveolar surface of the lung. Following inhalation, the bacilli
are rapidly encountered by host alveolar macrophages and other
phagocytic innate immune cells (such as dendritic cells), which
serve as key innate immune effector cells that provide the first
line of defense against the pathogen. At this stage, bacilli can be
destroyed by the antimicrobial actions of the macrophage; how-
ever, bacilli that evade intracellular destruction can persist and
multiply within infected macrophages. This results in the migra-
tion of infected macrophages to regional lymph nodes, where
protective TH1 cell immunity is induced through the recruitment
and interaction of additional innate and adaptive immune cells,
culminating in the formation of granulomas – organized com-
plexes of immune cells composed of lymphocytes, non-infected
macrophages, and neutrophils that contain infected macrophages
and prevent the dissemination of bacilli (5, 31, 32). However, in
most cases, the pathogen is not eliminated by the host; rather,
the pathogen persists in a dormant stage within the granuloma
for prolonged periods of time, becoming metabolically and repro-
ductively active following the breakdown of the granuloma and
dysregulation of protective T-cell immunity. This results in the
development of active tuberculosis, causing immunopathology in
the host and enabling the transmission of infection (31).
MAP INFECTION AND JOHNE’S DISEASE
Johne’s disease, caused by infection with MAP, is a chronic inflam-
matory disease that affects the gastrointestinal tract of cattle and
other ruminants. Specifically, JD presents as a granulomatous
inflammation of the intestinal tissue and regional lymph nodes due
to a massive influx of monocytes and macrophages. This inflam-
mation effectively prevents absorption of nutrients, and, therefore,
during the later stages of disease cattle manifest significant weight
loss and diarrhea, resulting in progressive physiological wasting
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and death. Disease progression is generally classified into four
stages: silent infection, subclinical, clinical, and advanced clini-
cal disease; in particular, the subclinical phase can be extremely
lengthy (between 2 and 5 years), with pathology largely restricted
to the ileum, rendering diagnosis difficult (24).
Exposure to MAP in ruminants generally occurs within the first
months of life, through either a fecal–oral route or by ingestion
of contaminated colostrum or milk, although evidence suggests
that some infections can occur in utero (33). Following ingestion,
the bacilli colonize the mucosa-associated lymphoid tissues of the
upper gastrointestinal tract and are subsequently endocytosed by
the microfold cells (M-cells) that cover the ileal Peyer’s patches.
The bacilli are subsequently phagocytosed by subepithelial and
intraepithelial intestinal macrophages, where they reside and mul-
tiply (34). The subsequent host cellular immune response leads to
the development of granulomas involving adjacent lymph nodes.
After years of latent infection, bacilli are assumed to reactivate and
trigger a state of active cellular proliferation, leading to the corru-
gated intestinal epithelia and clinical manifestations with shedding
of bacilli into the environment and grassland completing the infec-
tion cycle. The disease finally presents as a malnutrition syndrome
that culminates in the death of the animal (3, 35, 36).
Johne’s disease has major implications for domestic animal
health worldwide causing significant economic loss in affected
herds, which is largely due to decreased milk yields, reduced
slaughter weight, premature culling of infected animals, and losses
due to continued spread of infection (37). In cattle, JD results in
estimated losses of $250 million to the US dairy industry annu-
ally, while dairy herd prevalence of JD is estimated to be greater
than 50% in certain US states and European countries (35, 38, 39).
Furthermore, it has been hypothesized that MAP infection may
trigger or exacerbate Crohn’s disease, an inflammatory disease of
the intestines in human beings with similar granulomatous pathol-
ogy at the ileocecal valve; however, this proposed link between
MAP infection and Crohn’s disease remains contentious (40).
THE ROLE OF THE MACROPHAGE DURING MYCOBACTERIAL
INFECTION
Although BTB and JD exhibit distinct complex etiologies, the
causative agents of these diseases display a propensity to infect,
reside, and replicate in host macrophages – the key host innate
immune cell that mediates the immune response following infec-
tion. Macrophage recognition of mycobacteria occurs through
the interaction of mycobacterial pathogen-associated molecu-
lar patterns (PAMPs) – such as lipopolysaccharide, and various
lipoproteins and glycolipids (e.g., lipoarabinomannan) – with host
pathogen recognition receptors (PRRs) proteins, such as Toll-like
receptors (TLRs), which are expressed on the macrophage cell
surface (41). Macrophage PRR activation induces signaling path-
ways resulting in the production of endogenous NF-κB-inducible
cytokines and chemokines that promote a TH1 immune response
characterized by the release of proinflammatory IFN-γ, primar-
ily from CD4+ T-cells, and the lysing of infected macrophages
by cytotoxic CD8+ T-cells. IFN-γ induces microbicidal activity
in infected macrophages and enhances the expression of major
histocompatibility complex (MHC) class I and II molecules nec-
essary for the presentation of mycobacterial antigens on the
macrophage cell surface to CD8+ and CD4+ T-cells, respectively.
These mechanisms can lead to either the immediate killing of the
pathogen and clearing of infection,or the containment of infection
through the formation of granulomas (42–45).
Pathogenic mycobacteria have evolved a diverse range of
immunoevasive mechanisms that facilitate survival and replica-
tion within the host macrophage. These immunoevasive mecha-
nisms include inhibition of phagosome maturation necessary for
destruction of the pathogen and antigen presentation (46, 47);
evasion of macrophage apoptosis and activation of macrophage
necrosis, which facilitates release of bacilli from the macrophage
and encourages dissemination of infection to other cells (7, 48);
and the subversion of innate cell signaling, which is critical to the
establishment of infection and progression to active disease (49,
50). It has also been recently demonstrated that virulent M. tuber-
culosis strains preferentially infect permissive macrophages and
evade microbicidal macrophages through the masking of PAMPs
with cell surface associated lipids (51).
Failure or subversion of an appropriate innate immune
response is critical to the establishment of infection and progres-
sion to disease; central to this process is the macrophage response
to infection (31). Consequently, analysis of the bovine macrophage
response to in vitro infections with M. bovis and MAP may provide
insights into the cellular mechanisms that underlie and govern the
divergent immunopathology of BTB and JD (36, 52).
FUNCTIONAL GENOMICS ANALYSIS OF THE BOVINE
MACROPHAGE RESPONSE TO MYCOBACTERIA
Early investigations of the bovine macrophage response to
mycobacterial infection focused on the analysis of the expres-
sion of single or small numbers of immunological parameters.
For example, the quantification of gene or protein expression
using reverse transcription quantitative real-time PCR (RT-qPCR)
and ELISA technologies; however, focused studies such as these,
are unable to provide a high-resolution overview of the global
macrophage response to infection. Pathogen-induced activation
of host macrophages is characterized by large-scale changes in the
expression profile of genes critical for the control and eradication
of the pathogen, while modulation of host gene expression critical
for pathogen survival is also expected to be reflected in the tran-
scriptome of the macrophage (53, 54). Consequently, genomics
technologies that assay pan-genomic changes in gene expression
have been widely used to discern patterns of host-gene regula-
tion during infection. In particular, the development of high-
throughput gene expression technologies, such as microarrays and
RNA-sequencing (RNA-seq), over the past decade, coupled with
dramatic improvements in mammalian genome resources and
increasingly sophisticated computational tools for the analysis of
large-scale gene expression datasets are providing new opportu-
nities for detection, cataloging, and analysis of the large numbers
of host macrophage genes expressed in response to mycobacterial
infection in cattle (55–64).
A primary goal of our research group is to use high-
throughput functional genomics technologies to analyze the
bovine macrophage transcriptome following infection with M.
bovis and M. paratuberculosis to improve our understanding of
host–pathogen interactions that characterize and underlie BTB
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and JD. Previously, we used a 24-h time course infection model
to investigate the transcriptome response of bovine monocyte-
derived macrophages (MDM) infected with M. bovis and MAP
using data generated from the Affymetrix® GeneChip® Bovine
Genome microarray platform (61, 62). These analyses revealed a
large number of differentially expressed (DE) genes following M.
bovis infection relative to non-infected control MDM such that the
number of DE genes also increased across the time course, with
the highest number observed 24 h post-infection [hpi] (62). This
contrasted with results from MAP-infected MDM relative to the
same control macrophages, which showed the highest number of
DE genes at the 2 hpi time point with a decrease in the number of
DE genes at the later time points post-infection (i.e., 6 and 24 hpi)
(61). These findings suggest that M. bovis and MAP have differ-
ential survival strategies once internalized by macrophages, which
in turn, may underlie the divergent immunopathology associated
with BTB and JD.
THE MONOCYTE-DERIVED MACROPHAGE INFECTION
MODEL AND GENE EXPRESSION DATASETS USED FOR
COMPARATIVE FUNCTIONAL ANALYSIS
To further investigate the similarities and differences of the
bovine MDM response to virulent and attenuated mycobacterial
species/strains, we have reanalyzed and directly compared the
Affymetrix® GeneChip® Bovine Genome microarray data from
our earlier work (i.e., the non-infected control MDM and the
M. bovis- and MAP-infected bovine MDM) together with cor-
responding microarray data from MDM infected with M. bovis
BCG (65). All infected and control MDM used to generate these
data were derived from the same seven age-matched Holstein-
Friesian females, while a multiplicity of infection (MOI) of 2:1 (i.e.,
2 bacilli:1 MDM) was used for all MDM infections (61, 62). Gene
expression omnibus (GEO) data series accession numbers used for
these re-analyses were GSE33309, GSE35185, and GSE59774 (66).
For this new comparative analysis, gene expression data from
M. bovis-, MAP-, and M. bovis BCG-infected MDM together with
data from the non-infected control MDM at time points 2, 6, and
24 hpi were used. Prior to differential gene expression analysis, all
microarray data were quality checked using the arrayQualityMet-
rics package in Bioconductor (67). Raw data from two microarrays
(one MAP- and one M. bovis BCG infected MDM sample) did not
pass the QC thresholds set in the arrayQualityMetrics package
and were removed from all further downstream analyses. Further-
more, all arrays generated from these two animals were excluded
to ensure a balanced experimental design for comparative gene
expression analysis (Figure 2). Next, all raw gene expression data
FIGURE 2 |The experimental design used for the comparative
functional genomics analysis described in the current study.
Previously, MDM from seven age-matched females were infected with
M. bovis and MAP (MOI 2:1); control MDM received culture media only
(61, 62). We also infected, in parallel, MDM from the same animals with
M. bovis BCG (MOI 2:1). Infections were performed across duplicate
tissue culture plate wells (shaded circles); total RNA from duplicate
treatment wells was harvested and pooled at 2, 6, and 24 hpi.
Pan-genomic gene expression data for each RNA sample was generated
using the Affymetrix® GeneChip® Bovine Genome microarray platform
(61, 62). For the comparative functional genomics analysis, microarray
data from only five of these animals were used to ensure a balanced
experimental design following quality control assessment (see main
body text for details).
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were normalized and filtered for non-informative probe sets using
the I/NI algorithm implemented in the FARMS Bioconductor soft-
ware package (version 1.14.0) (68); this analysis yielded 11,842
informative probe sets for use in downstream analysis.
The 11,842 informative probe sets identified post-filtering were
then used to generate a multi-dimensional scaling (MDS) plot
summarizing the transcriptomic relationship between samples
(Figure 3). Notably, samples clustered according to time on the
first dimension, while the second dimension clustered samples
according to animal ID. However, there was a noticeable clus-
tering of RNA samples from M. bovis BCG- and MAP-infected
samples within each group of samples corresponding to a partic-
ular animal at a given time. Investigation of the expressed genes
with the greatest animal effect revealed that loci within the bovine
MHC displayed the greatest differences in expression among ani-
mals with relatively small gene expression differences within each
animal across time and treatment (Figure S1 in Supplementary
Material). The magnitude of the expression differences among
animals for these genes presumably contributes to the separation
of the samples by animal on the second dimension in the MDS
plot (Figure 3).
We propose two hypotheses to explain the observed expres-
sion differences among animals. First, expressed MHC loci, which
are among the most polymorphic loci in mammals, generate
mRNA transcripts that display considerable nucleotide differ-
ences between individuals from the same species (69–71). mRNA
transcripts that vary appreciably from the reference transcript
sequences used to produce the microarray probe sets may, there-
fore, have a reduced hybridization efficiency compared to mRNA
transcripts that are identical to or differ only slightly from the
reference transcript sequences. In turn, this may result in Type
1 errors for differential gene expression estimates between sam-
ples or sample groups (72–74). Consequently, the animal effect
observed in these data may be due, in part, to the technical limita-
tions of the microarray platform used. Second, it is possible that
the observed inter-animal differential gene expression is due, in
part, to real differences in mRNA abundance generated by geno-
typic differences at loci that regulate gene expression (71, 74, 75);
indeed, genotypic differences at loci that regulate gene expression
in response to mycobacterial infection may contribute to pheno-
typic differences in the ability of an animal to clear or succumb to
infection. In addition, a combination of both these technical and
biological factors could also explain the observed animal effect.
COMPARATIVE FUNCTIONAL GENOMICS ANALYSIS
REVEALS SIMILARITIES AND DIFFERENCES IN THE
MACROPHAGE TRANSCRIPTOME RESPONSE TOM. bovis,
MAP, ANDM. bovis BCG
Figure 4 shows the results of differential gene expression analysis
for the infected MDM (i.e., M. bovis, MAP, and M. bovis BCG) rela-
tive to the non-infected control MDM [false-discovery rate (FDR)
adjusted P value≤0.05]. Notably, for each infected MDM/control,
MDM contrast the number of DE genes varied with respect to
time. M. bovis-infected MDM exhibited the greatest number of
DE genes, with the number of DE genes increasing across the 24-h
time course. Furthermore, for M. bovis, the number of downreg-
ulated genes exceeded the number of upregulated genes at each of
the time points post-infection.
In contrast, the number of DE genes observed for both
the MAP- and M. bovis BCG-infected MDM (relative to the
FIGURE 3 | Multi-dimensional scaling (MDS) plot of the infected MDM at each time point post-infection. Manhattan distances (calculated from 11,842
informative probe sets) were used to generate the MDS plot.
Frontiers in Immunology | Molecular Innate Immunity November 2014 | Volume 5 | Article 536 | 6
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Rue-Albrecht et al. Bovine macrophages and mycobacterial infections
FIGURE 4 |The number of DE genes found for paired comparisons of
infected MDM (i.e., MDM infected with M. bovis/MAP/M. bovis BCG)
relative to the control MDM for each time point post-infection
(FDR≤0.05). Bars above the horizontal line (i.e., y =0) indicate the number
of genes displaying upregulation in the infected MDM relative to the control
MDM; bars below the horizontal line indicate the number of genes
displaying downregulation in the infected MDM relative to the control
MDM.
non-infected controls) was highest at the 6 hpi time point for both
sample groups (Figure 4). These results indicate that for MAP
and M. bovis BCG infection, MDM differential gene expression
had largely abated at the 24 hpi time point and that the MDM
transcriptome reverted to a transcriptional state similar to that
of the control MDM. These observations support previous work
that showed that differential gene expression changes in MAP-
infected bovine MDM are transient and are largely undetected
24 hpi relative to non-infected control MDM (76, 77).
A comparison of the lists of DE genes obtained for all mycobac-
teria/control contrasts at each time point (Figure 5) identified
a core set of DE genes at the 2 and 6 hpi time points com-
mon to all three mycobacterial treatments consisting of 170 and
236 DE genes, respectively. Among the DE genes common to
all three mycobacterial infections were IL1A, IL1B, TNF, NFKB1,
and NFKB2; all of these genes were upregulated at one or more
time points in all types of infected MDM, suggesting a robust
inflammatory reaction to all of the mycobacteria used in this
study. Ingenuity® Systems Pathway Analysis (IPA; Ingenuity Sys-
tems, Redwood City, CA, USA; www.ingenuity.com) was used to
identify canonical pathways within the list of DE genes that were
common to all three mycobacterial treatments relative to the con-
trol group. The top ranking canonical cellular pathways (based on
the lowest adjusted P-values; FDR≤ 0.05) enriched for the 170
and 236 common DE genes identified at 2 and 6 hpi included
IL-10 signaling (2 hpi); dendritic cell maturation (2 and 6 hpi);
IL-6 signaling (2 hpi); TNFR2 signaling (2 hpi), TWEAK signaling
FIGURE 5 |The number of shared and unique DE genes among the three infected MDM groups based on gene expression data relative to the control
MDM (FDR≤0.05). Red shading denotes M. bovis-infected MDM; green shading denotes MAP-infected MDM; blue shading denotes M. bovis BCG
(BCG)-infected MDM.
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(2 hpi); communication between innate and adaptive immune cells
(6 hpi), NF-κB signaling (6 hpi); and TREM1 signaling (2 and
6 hpi; FDR≤ 0.0001) (see Tables S1 and S2 in Supplementary
Material).
We also observed large numbers of DE genes that were specific
to M. bovis-infected MDM, which increased over time from 1,013
significant genes at 2 hpi to 2,167 at 24 hpi (Figure 5). The percent-
ages of DE genes unique to M. bovis infection relative to the total
number of DE genes detected following M. bovis infection were
80.3% (2 hpi), 78.8% (6 hpi), and 96.6% (24 hpi). IPA analysis
of the DE genes unique to M. bovis-infected macrophages across
all three time points (Tables S3–S5 in Supplementary Material)
revealed enrichment for genes involved in cell signaling, includ-
ing IL-6 signaling and mitogen-activated protein kinase (MAPK)
signaling, the latter of which regulates the expression of several
transcription factors, such as those encoded by FOS and JUN that
are critical for the activation of immune cells (78). In contrast, the
number of DE genes specific to MAP and M. bovis BCG infec-
tion across the time course was markedly lower; for example, no
gene was specific to either MAP or M. bovis BCG infection 24 hpi.
Indeed, for each post-infection time point, more than 98.3% of the
DE genes induced by MAP and M. bovis BCG relative to the con-
trols were among the list of DE genes induced by M. bovis relative
to the controls.
We next analyzed differential gene expression directly between
each pair of mycobacteria-infected sample groups (Figure 6).
Large and increasing numbers of DE genes were found across the
time course in M. bovis-infected MDM relative both MAP- and
BCG-infected MDM, confirming the divergence between the two
types of MDM transcriptional responses. Notably, no DE genes
were detected between MAP- and BCG-infected MDM at 2 and
6 hpi, while only two DE genes were identified at 24 hpi; this con-
trasts with the larger numbers of DE genes identified through
the indirect comparison of MAP- and BCG-infected MDM using
the controls as a common reference (Figure 5). This discrep-
ancy is most readily explained by differences in variances of gene
expression within each sample group as illustrated in Figure S2 in
Supplementary Material.
The overlap in DE genes across all three treatment groups
(relative to the control groups) at the 2 and 6 hpi time points sug-
gest that a “core” MDM transcriptional response is induced by all
three mycobacterial species/strains during the early stages of infec-
tion. This core transcriptome is characterized by genes involved in
innate cytokine signaling and production, which encode proteins
that activate the adaptive immune response following mycobac-
terial infection. However, the large and increasing number of DE
genes specific to M. bovis across the infection time course demon-
strates that M. bovis is a more potent inducer of proinflammatory
genes than M. bovis BCG or MAP and highlights the distinct MDM
gene expression profile elicited in response to this pathogen. In
addition, the enrichment of M. bovis-specific DE genes for roles
in macrophage cell signaling, such as IL-6 and MAPK signaling,
suggests that additional cellular pathways are triggered by this
pathogen relative to M. bovis BCG or MAP.
Although proinflammatory cytokines and chemokines play a
pivotal role in mediating the host immune response to con-
trol mycobacterial infection, several lines of evidence suggest
FIGURE 6 |The number of DE genes found for pairwise comparisons
among infected MDM groups (FDR≤0.05). Bars above the horizontal line
(i.e., y =0) indicate the number of genes displaying upregulation; bars
below the horizontal line indicate the number of genes displaying
downregulation.
that these molecules and their associated pathways can be
exploited by virulent mycobacterial pathogens to promote gran-
uloma formation, which recruit new macrophages to the site of
infection enabling persistence within the host (79). For exam-
ple, non-regulated production of proinflammatory cytokines
and chemokines can result in immunopathology, including
destructive inflammation and necrosis, allowing dissemination
of the pathogen from infected cells (9, 80, 81). Therefore, the
immunopathology of BTB may be associated with the increased
induction of innate immune genes following infection with M.
bovis. Furthermore, the divergent transcriptomic profile observed
in MDM infected with virulent M. bovis relative to M. bovis BCG-
infected MDM is presumably governed, in part, by the presence
of several secreted virulence factors, such as those encoded by the
RD1 locus (57, 82, 83). This locus is present in all virulent strains
of M. bovis (and M. tuberculosis) but is absent in attenuated strains
of M. bovis BCG (84).
Conversely, the reduced number of DE genes detected between
the MAP-infected and the non-infected control and M. bovis BCG-
infected MDM across the time course suggests that MAP infection
does not result in a major perturbation of the MDM transcrip-
tome; rather, bovine MDM sense and respond to MAP in a similar
manner to attenuated M. bovis BCG despite their markedly dis-
tinct evolutionary histories and different pathogenicities. These
results support the hypothesis that MAP infection of host MDM
is achieved via a capacity to appear “benign,” which enables it to
reside and replicate within the macrophage for prolonged periods
of time, and may underlie the lengthy subclinical phase of infection
characteristic of JD (85). Our results also suggest that the immu-
noevasive mechanisms used by MAP involve the suppression of
the proinflammatory response, such that the transcriptome of an
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infected macrophage resembles that of a non-infected cell. In sup-
port of this, in vivo MAP infection models demonstrate that cattle
initially develop an early proinflammatory and TH1-type response
to infection, which gradually declines in animals that progress to
active disease, favoring a TH2-type response that does not control
infection (3, 86–88). Notably, the immunosuppression observed
in vivo may originate at a cellular level, whereby MAP-infected
macrophages fail to properly respond to host-derived immune
activators such as CD40L and IFN-γ (89, 90).
TRANSCRIPTIONAL EVIDENCE FOR TYPE I
INTERFERON-MEDIATED REGULATION OF INTERLEUKIN I
PRODUCTION INM. bovis-INFECTED MDM: TOWARD A
MECHANISM OF PATHOLOGY
Examination of the lists of DE genes for each mycobacterial
infection/control contrast shows that type I interferon-inducible
genes such as IFIT1, IFIT2, MX1, MX2, and IL27 and interferon-
dependent CXCL10 were not DE following MAP and M. bovis
BCG infection at any of the post-infection time points. However,
all of these genes were DE for at least one time point following
M. bovis infection (Table 1). Similarly, the gene encoding type II
interferon (i.e., IFNG) was also upregulated at 6 and 24 hpi fol-
lowing M. bovis infection, but was not DE at any post-infection
time point following infection with MAP and M. bovis BCG. We
further observed that, in general, the fold-change of upregulation
of the type I and type II interferon-inducible genes increased over
the time course of infection in the M. bovis-infected MDM, with
an accompanying decrease in the fold-change of upregulation of
the interleukin-1 genes (IL1A and IL1B).
IL-1 and type I IFN-signaling pathways have been shown to play
important, yet opposing, roles in determining the host response to
infection with virulent members of the MTBC. Mice deficient in
IL-1B display increased susceptibility to virulent M. tuberculosis,
indicating that IL-1 signaling is required for the host control of
infection (91, 92). Conversely, mice deficient in type I IFN signal-
ing show reduced bacterial loads following infection, suggesting
that type I IFN plays a contributory role in tuberculosis disease
progression (93, 94). Studies have also shown that virulent M.
tuberculosis and attenuated M. bovis BCG use distinct signaling
pathways for regulating IL-1B production in human MDM. M.
tuberculosis induced the expression of IFN-related genes, while
induction of type I IFN-signaling inhibited IL-1B secretion (95,
96). Notably, infection of human MDM with M. bovis BCG did
not induce significant differential expression of IFN-related genes
or IL-1B secretion. These results suggest that type I IFN-mediated
suppression of IL-1B production is a key mechanism for the intra-
cellular survival of M. tuberculosis (95, 96). Comparable in vivo
and in vitro studies of bovine ileal tissue and MDM have demon-
strated increased transcript and protein levels of IL-1A and IL-1B
(in vitro only) in response to MAP infections, with a concomi-
tant increase in downstream expression of TRAF1 (97, 98). This
increase in TRAF1 has been proposed to enhance survival of MAP
Table 1 | Log2 fold-change values of manually curated genes for several immune-related pathways.
M. bovis vs CN M. bovis BCG vs CN MAP vs CN M. bovis vs
M. bovis BCG
M. bovis vs MAP
2hpi 6hpi 24hpi 2 hpi 6 hpi 24hpi 2 hpi 6 hpi 24hpi 2 hpi 6 hpi 24hpi 2 hpi 6 hpi 24hpi
IL-1 signaling genes
IL1B 5.68 4.04 2.85 4.14 3.77 1.54 2.80 1.80 1.91 2.71 2.18
IL1A 5.37 2.42 2.50 4.21 3.88 1.16 1.91 1.64 1.49 1.85 2.16
Type 1 interferon-related genes
IFNB1 0.76 0.79 0.66
IFNAC 0.17 0.18 0.18
CXCL10 2.04 2.89 3.00 2.10 1.92
IFIT2 2.27 1.94 1.70
MX1 1.18 1.07 0.85
MX2 1.99 1.43 1.41
IFNAR1 0.33
IFNAR2 0.20 0.24 0.25 0.20 0.21 0.19 0.17 0.20 0.25
Type 2 interferon-related genes
IFNG 2.06 1.88 1.49 1.78 2.02
IFNGR2
IFNGR2 0.15
NF-κB-related genes
NFKB1 1.47 1.19 0.61 0.98 0.89 1.00 0.58 0.50 0.43 0.48 0.61 0.53
NFKB2 2.59 3.07 1.84 1.74 2.30 1.69 1.87 0.85 0.77 1.14 0.89 1.20 1.38
TNF 5.11 3.98 2.30 4.11 1.39 3.55 1.47 2.59 1.52 1.57 2.51 2.04
IL6 4.49 2.15 3.12 2.86 2.40 1.63 1.67 2.20 2.09 1.57 2.73
Cells containing values are statistically different for the contrasts listed in the column headings (FDR≤0.05); empty cells are not statistically different (FDR≥0.05).
The intensity of the shading is related to relative increased fold-changes in gene expression.
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in macrophages due to the anti-apoptotic properties of TRAF1
and its capacity to interfere with normal macrophage activation,
particularly via CD40/CD40L (98, 99).
The increase in type I IFN gene expression and the concomitant
decrease in IL1 induction that we observed in M. bovis-infected
MDM over the 24-h infection time course suggests that the
intracellular survival strategy of virulent M. bovis may also involve
type I IFN-mediated suppression of IL1 production. In contrast
to this, these results suggest that the same immunoevasive mech-
anism is not used by virulent MAP or the attenuated M. bovis
BCG in bovine MDM. These results indicate that differential acti-
vation of macrophage immunoregulatory pathways is central to
the differential intracellular survival mechanisms of these related,
yet distinct, bovine mycobacterial pathogens. A proposed model
of the differential response of bovine MDM to the mycobacteria
examined in this comparative study is shown in Figure 7.
DIFFERENTIAL MYCOBACTERIAL VIRULENCE FACTORS AND
THEIR IMPACT ON MACROPHAGE PATHOGEN RECOGNITION
The region of difference 1 (RD1) locus,which is present in M. bovis,
is a major genetic difference between this species and MAP and
M. bovis BCG, which both lack RD1 (100). Moreover, RD1 (which
is also present in virulent M. tuberculosis strains) has attracted
increasing interest over the last two decades, because it contains the
ESX-1 type VII secretion system, responsible for the secretion of
virulence factors, such as the dimer ESAT-6/CFP-10 (101). ESAT-6,
which is proposed to facilitate escape from macrophage phagolyso-
somal degradation, binds to TLR2 receptors, and activates TLR
signaling cascades within the macrophage that culminate in
cytokine production (102–104). It has been recently reported that
TLR2 receptors mediate enhanced interferon production through
reprograming of murine macrophages following infection with
viral ligands (105). In support of these observations, our results
showed that differential expression of both type I and type II inter-
feron genes is unique to M. bovis-infected MDM, which is not
present in MDM infected with MAP and M. bovis BCG. Conse-
quently, we hypothesize that the virulence factors encoded in the
RD1 region and secreted by M. bovis – but not MAP or M. bovis
BCG – trigger an additional cascade of signaling events, such as
those mediated by TLRs and MAPKs (as revealed through IPA
analyses of unique M. bovis-induced genes), relative to attenuated
M. bovis BCG and the lengthy subclinical MAP. In turn, the com-
bined activation of additional immune pathways and canonical
PRR-dependent pathways may lead to a sustained (i.e., chronic)
inflammatory response in infected macrophages, as opposed to
a more transient inflammation following M. bovis BCG or MAP
infections.
CONCLUDING REMARKS
In the present study, we highlight markedly different transcrip-
tional response of bovine MDM infected with M. bovis over a
24-h time course compared to the closely related but attenuated
M. bovis BCG strain and to virulent MAP. We hypothesize that
RD1-encoded virulence factors provide a mechanistic basis for
this differential response, as RD1 was lost during the derivation
of the M. bovis BCG vaccine strain from M. bovis and is absent
from the MAP genome. We also identified a common MDM tran-
scriptional response to both attenuated M. bovis BCG and MAP.
We propose that the respective attenuated and lengthy subclini-
cal phenotypes of M. bovis BCG and MAP may induce similar
responses in infected macrophages, at least during the early stages
of infection. Finally, we identified type I interferon-dependent
FIGURE 7 | A proposed model for the differential responses of bovine MDM to M. bovis,M. bovis BCG, andM. avium subsp. paratuberculosis
infection in vitro. Differential integration of common and specific signals induced by the three mycobacterial types is shown.
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genes among the DE genes specific to virulent M. bovis-infected
MDM, adding further evidence supporting a key role for type I
interferon in the establishment of active tuberculosis in cattle as
has previously reported for human tuberculosis (106).
While the comparative functional genomics analysis presented
here is based on data generated from microarrays, the changing
landscape of transcriptomics, as represented by the advent of high-
throughput RNA-seq, offers unprecedented opportunities to study
the host macrophage response to mycobacterial infection at the
nucleotide level, including investigation of the effect of genotype
on gene expression levels. High-throughput sequencing technolo-
gies are providing novel insights into the cellular mechanisms
governing mycobacteria–macrophage interactions, enabling fur-
ther understanding of how modulation of these pathways can
result in pathology. In addition, identification of transcriptional
biomarkers of infection may lead to the development of novel
diagnostics for BTB and JD, providing new molecular tools for
disease control and eradication.
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